Evidence map›Paper›PMID 38371208›Full record

ArticleBJUI compass2024

Diagnostic value of repeated comprehensive investigation with CT urography and cystoscopy for recurrent macroscopic haematuria.

Suleiman Abuhasanein, Vanessa Chaves, Ali Moustafa Mohsen, Jasmine Al-Haddad, Merete Sunila, Viveka Ströck, Tomas Jerlström, Fredrik Liedberg, Jesper Swärd, Truls Gårdmark and 2 more

Open access · goldAbstract read
In one paragraph

Article in BJUI compass, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Suleiman AbuhasaneinDepartment of Urology, Institute of Clinical Science, Sahlgrenska Academy University of Gothenburg Göteborg Sweden.ORCID https://orcid.org/0000-0003-3756-0397
Vanessa ChavesDepartment of Surgery, Urology Section NU Hospital Group Uddevalla Sweden.
Ali Moustafa MohsenDepartment of Surgery, Urology Section NU Hospital Group Uddevalla Sweden.
Jasmine Al-HaddadDepartment of Surgery, Urology Section NU Hospital Group Uddevalla Sweden.
Merete SunilaDepartment of Surgery, Urology Section NU Hospital Group Uddevalla Sweden.ORCID https://orcid.org/0000-0002-1826-4253
Viveka StröckDepartment of Urology, Institute of Clinical Science, Sahlgrenska Academy University of Gothenburg Göteborg Sweden.
Tomas JerlströmDepartment of Urology, School of Medical Sciences, Faculty of Medicine, and Health Örebro University Örebro Sweden.
Fredrik LiedbergDepartment of Urology Skåne University Hospital, Malmö, Sweden and Institution of Translational Medicine Lund University Malmö Sweden.ORCID https://orcid.org/0000-0001-8193-0370
Jesper SwärdDepartment of Urology, Institute of Clinical Science, Sahlgrenska Academy University of Gothenburg Göteborg Sweden.
Truls GårdmarkDepartment of Clinical Sciences, Danderyd Hospital Karolinska Institute Stockholm Sweden.
Staffan JahnsonDepartment of Clinical and Experimental Medicine, Division of Urology Linköping University Linköping Sweden.ORCID https://orcid.org/0000-0001-8012-2742
Henrik KjölhedeDepartment of Urology, Institute of Clinical Science, Sahlgrenska Academy University of Gothenburg Göteborg Sweden.ORCID https://orcid.org/0000-0001-6441-4729
NU Hospital Group · SESahlgrenska University Hospital · SEKarolinska University Hospital · SELinköping University · SELund University · SEÖrebro University · SEUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To perform a descriptive analysis of a series of patients with recurrent macroscopic haematuria after a primary standard evaluation including computed tomography urography (CTU) and cystoscopy negative for urinary bladder cancer (UBC) and upper tract urothelial cancer (UTUC) and to identify potential factors associated with occurrence of recurrent macroscopic haematuria. Methods: All patients older than 50 years who underwent urological investigation for macroscopic haematuria with both cystoscopy and CTU 2015-2017 were retrospectively reviewed. A descriptive analysis of the primary and later investigations for recurrent macroscopic haematuria was performed. To investigate the association between explanatory variables and the occurrence of recurrent macroscopic haematuria, a Poisson regression analysis was performed. Results: A total of 1395 eligible individuals with primary standard investigation negative for UBC and UTUC were included. During a median follow-up of 6.2 (IQR 5.3-7) years, 248 (18%) patients had recurrent macroscopic haematuria, of whom six patients were diagnosed with UBC, two with prostate cancer, one with renal cell carcinoma and one had a suspected UTUC at the repeated investigation. Within 3 years, 148 patients (11%) experienced recurrent macroscopic haematuria, of whom two patients were diagnosed with low-grade UBC (TaG1-2), one with T2G3 UBC and one with low-risk prostate cancer. The presence of an indwelling catheter, use of antithrombotic medication, pathological findings at CTU or cystoscopy or history of pelvic radiotherapy were all statistically significant independent predictors for increased risk for recurrent macroscopic haematuria. Conclusion: In the case of recurrent macroscopic haematuria within 3 years of primary standard evaluation for urinary tract cancer, there was a low risk of later urological malignancies in patients initially negative for UBC and UTUC. Therefore, waiting 3 years before conducting another complete investigation in cases of recurrent macroscopic haematuria might be appropriate.

Indexed as

bladder cancercomputed tomographycystoscopyhaematuriarecurrenturographyurological neoplasm

Identifiers

PMID38371208
PMCPMC10869664
OpenAlexW4387433847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.